Cabergoline and cardiomegaly Patient Reports February 12, 2012
Cabergoline Side Effects Report #4825201-X
Cabergoline side effect was reported by a Physician from SPAIN on Nov 03, 2005. Male patient, 74 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac valve disease, cardiomegaly, dilatation atrial, mitral valve incompetence. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4934700-1
Cabergoline side effect was reported by a Physician from SPAIN on Feb 20, 2006. Male patient, 74 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac failure, cardiac murmur, cardiac valve disease, cardiomegaly, dilatation atrial, gallop rhythm present, mitral valve incompetence, oedema peripheral. Cabergoline dosage: 4 MG (2 MG, 2 IN 1 D). Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5127987-6
Cabergoline side effect was reported by a Physician from JAPAN on Sept 27, 2006. Male patient, 82 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve disease, aortic valve incompetence, blood pressure diastolic decreased, cardiac murmur, cardiomegaly, mitral valve disease, mitral valve incompetence, oedema peripheral, pulmonary congestion. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4690050-2
Cabergoline side effect was reported by a Health Professional from on May 31, 2005. Female patient, 80 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood bicarbonate increased, blood ph decreased, cardiac failure congestive, cardiomegaly, fluid imbalance, myocardial infarction, myocardial ischaemia, oedema peripheral, pco2 increased. Cabergoline dosage: 1 MG (1 MG, QD), ORAL. During the same period patient was treated with MADOPAR, SYMMETREL, MICARDIS, SELBEX, AMLODIPINE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4996295-6
Cabergoline side effect was reported by a Physician from SPAIN on Apr 27, 2006. Male patient, 73 years of age, weighting 213.8 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic elongation, aortic valve incompetence, aortic valve sclerosis, atrial fibrillation
, cardiac failure, cardiac murmur, cardiomegaly. Cabergoline dosage: 3 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4645346-7
Cabergoline side effect was reported by a Physician from on Apr 11, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: akinesia, aortic valve incompetence, blood pressure systolic increased, cardiac failure, cardiomegaly, dilatation atrial, dyspnoea exertional, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 2 MG , ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4874914-2
Cabergoline side effect was reported by a Physician from SPAIN on Dec 28, 2005. Male patient, 72 years of age, weighting 213.8 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic disorder, aortic valve incompetence, aortic valve sclerosis, atrial fibrillation
, cardiac failure, cardiac murmur, cardiomegaly. Cabergoline dosage: 3 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4629438-4
Cabergoline side effect was reported by a Physician from on Mar 24, 2005. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aortic valve incompetence, cardiac failure, cardiac valve disease, cardiomegaly, condition aggravated, echocardiogram abnormal, mitral valve incompetence, palpitations. Cabergoline dosage: unknown. During the same period patient was treated with PERGOLIDE MESYLATE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5065721-9
Cabergoline side effect was reported by a Physician from JAPAN on July 12, 2006. Male patient, 64 years of age, weighting 127.9 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac disorder, cardiac failure, cardiomegaly, cardiomyopathy
, pleural effusion, pneumonia
, pulmonary congestion, supraventricular tachycardia. Cabergoline dosage: 3 MG (1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5072976-3
Cabergoline side effect was reported by a Physician from JAPAN on July 24, 2006. Male patient, 64 years of age, weighting 127.9 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomegaly, congestive cardiomyopathy, pleural effusion, pneumonia
, pulmonary congestion, supraventricular tachycardia. Cabergoline dosage: 3 MG (1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4850529-7
Cabergoline side effect was reported by a Physician from SPAIN on Nov 30, 2005. Male patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood lactate dehydrogenase increased, cardiomegaly, haemoptysis, mitral valve incompetence, nasopharyngitis, pulmonary hypertension
, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with AMANTADINE, DILUTOL, MOTILIUM, SINEMET, STALEVO, BESITRAN. Patient recovered.
Cabergoline and cardiomegaly 